| Dr Jeffrey I Scharf, MD | |
|
446 Bellevue Ave, Trenton, NJ 08618 | |
| (609) 394-4000 | |
| Not Available |
| Full Name | Dr Jeffrey I Scharf |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 446 Bellevue Ave, Trenton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568402642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MA035888 (New Jersey) | Primary |
| Entity Name | Trinity Health Mid-atlantic Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093771271 PECOS PAC ID: 7416861885 Enrollment ID: O20040326000613 |
News Archive
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.
Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
A medicinal chemist who found a cure for the viral disease hepatitis C has received a prestigious award from the University of Edinburgh.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey I Scharf, MD 446 Bellevue Ave, Trenton, NJ 08618-4502 Ph: (609) 394-4000 | Dr Jeffrey I Scharf, MD 446 Bellevue Ave, Trenton, NJ 08618 Ph: (609) 394-4000 |
News Archive
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.
Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
A medicinal chemist who found a cure for the viral disease hepatitis C has received a prestigious award from the University of Edinburgh.
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
› Verified 3 days ago
Dr. Michael B Resnick, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Hamilton Health Pl, Trenton, NJ 08690 Phone: 609-631-6899 Fax: 609-631-6898 | |
Dr. Hullur R Ramamurthy, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 416 Bellevue Ave, Suite 102, Trenton, NJ 08618 Phone: 609-393-2800 Fax: 609-278-7323 | |
Renee Hypolite, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 433 Bellevue Ave, Trenton, NJ 08618 Phone: 609-394-4111 | |
Dr. James M O'mara, M.D., PA Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1450 Parkside Ave, Suite #20, Trenton, NJ 08638 Phone: 609-530-1818 | |
Dr. Kimberly Staton Baldwin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 433 Bellevue Ave, Trenton, NJ 08618 Phone: 609-394-4111 Fax: 609-394-7040 | |
Alicia T Tesoro, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 321 N Warren St, Trenton, NJ 08618 Phone: 609-249-5900 Fax: 609-695-3532 | |
Dr. Wendy Lee Cervi, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 321 N Warren St, Trenton, NJ 08618 Phone: 609-278-5917 Fax: 609-278-4201 |